Suchergebnisse - (Subject:"Siltuximab")

PubPharm (31)

21

Siltuximab : a targeted therapy for idiopathic multicentric Castleman disease

enthalten in: Immunotherapy | 2016

von Fajgenbaum, D. | Kurzrock, R.

22

Strategy for the treatment of multiple myeloma utilizing monoclonal antibodies : A new era begins

enthalten in: Leukemia & lymphoma | 2016

von Magarotto, V. | Salvini, M. | Bonello, F. | +2

23

Siltuximab : A Review in Idiopathic (Human Herpesvirus-8-Negative) Multicentric Castleman Disease

enthalten in: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy | 2015

von Lyseng-Williamson, K.

24

Clinical development of siltuximab

enthalten in: Current oncology reports | 2015

von Davis, C. | Shah, K. | Lechowicz, M.

25

Interleukin-6 as a therapeutic target

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2015

von Rossi, J. | Lu, Z. | Jourdan, M. | +1

26

FDA approval : siltuximab for the treatment of patients with multicentric Castleman disease

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2015

von Deisseroth, A. | Ko, C. | Nie, L. | +11

CommentIn: Clin Cancer Res. 2015 Oct 15;21(20):4740. - PMID 26473194

27

Siltuximab : a new option for the management of Castleman's disease

enthalten in: Drugs of today (Barcelona, Spain : 1998) | 2015

von Barquero, N.

28

Siltuximab (Sylvant) for treatment of multicentric castleman's disease

enthalten in: The Medical letter on drugs and therapeutics | 2015

29

Siltuximab (CNTO 328) : a promising option for human malignancies

enthalten in: Drug design, development and therapy | 2015

von Chen, R. | Chen, B.

30

Siltuximab : first global approval

enthalten in: Drugs | 2014

von Markham, A. | Patel, T.